Rx Medical Food Market, by Product Type (Pills, Powder, Liquid and Others (wafers, chewables, and  bars)), by Therapeutic Application (Pain Management, Pain Management, Neurological Disorder, GI Disorder, Pulmonary Disorders, Metabolic Disorders, and Oth

Rx Medical Food Market, by Product Type (Pills, Powder, Liquid and Others (wafers, chewables, and  bars)), by Therapeutic Application (Pain Management, Pain Management, Neurological Disorder, GI Disorder, Pulmonary Disorders, Metabolic Disorders, and Others (fibrosis, dialysis, AIDS, etc.)) by Distribution Channel (Retail Pharmacies and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Medical food is consumed or enterally administered under the supervision of a physician for the treatment of a disease or specific dietary management. Medical food is used for various purposes such as healthy aging, maintaining brain health, and for treating chronic medical conditions such as irritable bowel syndrome and metabolic disorders. Medical food imitates therapeutic agents used in the treatment of clinical conditions such as pain, sleep disorders, and cognitive disorders. It provides relief from pain or helps treat the condition without exhibiting any risk or side effects that are usually associated with pharmaceutical drugs. Medical food products claiming treatment of such medical conditions or any other diseases are required to support their claim with proper scientific and clinical study results.
Medical food is a category of prescribed products which offer various advantages over prescription drugs such as lesser side effects, lower product costs, and nutritional benefits..
Although, medical food products do not require adherence to any particular labelling requirements, any false claims or misbranding may result in legal action from the Food, Drug & Cosmetic Act (FD & C Act). Medical food varies in forms of dosage such as powders, pills, and solutions, which offer a wider range of products to the patients’. Technical advancements in nutritional therapies for different disorders is a result of robust support of medical food research and approved products and their various therapeutic applications, which, to a certain extent is expected to diminish the use of prescription drugs usage.
Market Dynamics
Personalized medicine is a developing field, and gaining medical industry’s attention for its therapeutic application, where the patient’s genetic makeup is used to guide the prevention, diagnosis, and treatment of diseases. Medical food is expected to gain a strong foothold in the personalized medicine sector owing to innovative developments.
According to a report by the Personalized Lifestyle Medicine Institute, in 2013, 70% of all chronic diseases in the U.S. were due to nutrition deficiencies or imbalances. Such nutrition-based disease conditions could be directly addressed with the help of medical foods in the initial stages of the disease and prevent further loss. Thus, management of diseases by treating individual nutritional deficiencies is expected to favor demand for personalized medicines. The awareness about medical food and its benefits among healthcare professionals and patients is expected to drive growth of the market.
Key features of the study:
This report provides in-depth analysis of the global Rx medical food market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global Rx Medical Food Market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study are Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc. and AlfaSigma S.P.A.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global Rx Medical Food Market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the Rx Medical Food Market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Rx Medical Food Market, By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
Global Rx Medical Food Market, By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
Global Rx Medical Food Market, By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Global Rx Medical Food Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Product Type:
Pills
Powder
Liquid
Others (wafers, chewables, bars)
By Therapeutic Application:
Pain Management
Sleep Disorder
Neurological Disorder
GI Disorder
Pulmonary Disorders
Metabolic Disorders
Others (fibrosis, dialysis, AIDS, etc.)
By Distribution Channel:
Retail Pharmacies
Online Pharmacies
Company Profiles
Abbott Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Danone S.A.
Mead Johnson & Company, LLC.
Fresenius Kabi AG
Nestle S.A.
Primus Pharmaceuticals, Inc.
Targeted Medical Pharma Inc.
Pivotal Therapeutics Inc.
VAYA Pharma, Inc.
AlfaSigma S.P.A.
“*” marked represents similar segmentation in other categories in the respective section.